Pancreatic Cancer Research

ResearcherThe Cancer Institute HospitalActive in the last 2 years

Takeaki Ishizawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9534-6973; OpenAlex author ID A5077821391. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
66
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer. Last author DOI 10.21873/anticanres.18203↗
  2. Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: … Co-author DOI 10.1002/jhbp.12181↗
  3. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreat… Co-author DOI 10.1038/s41598-024-61142-y↗
  4. [Devising a Surgical Approach Using the Intestinal Derotation Procedure for Locally Advanced Pancreatic Cancer]. Last author PMID 39948948↗
  5. Pancreaticoduodenectomy with celiac artery resection (PD-CAR) for unresctable locally advanced pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00423-023-02860-1↗
  6. Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons' Perspectives on Curren… Co-author DOI 10.3390/cancers15030652↗
  7. Radical Antegrade Modular Pancreatosplenectomy for Left-Sided Pancreatic Ductal Adenocarcinoma May Reduce the Local Recurrence Rate. Co-author DOI 10.1159/000524927↗
  8. Fluorescence Imaging Using Enzyme-Activatable Probes for Real-Time Identification of Pancreatic Cancer. First author DOI 10.3389/fonc.2021.714527↗
  9. Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer. Co-author DOI 10.1007/s11605-019-04203-2↗
  10. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. Co-author DOI 10.1007/s11605-018-3995-3↗
  11. Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? Co-author DOI 10.1007/s11605-017-3421-2↗

Closest collaborators

The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroji Shinkawa · 3 shared papers, 2023–2026 · strength 0.66
  2. Kohei Nishio · 3 shared papers, 2023–2026 · strength 0.66
  3. Ryota Tanaka · 3 shared papers, 2024–2026 · strength 0.66
  4. Kenjiro Kimura · 3 shared papers, 2023–2024 · strength 0.53
  5. Kosuke Hatta · 2 shared papers, 2024–2026 · strength 0.48
  6. Shigeaki Kurihara · 2 shared papers, 2024–2026 · strength 0.48
  7. Kiyoshi Hasegawa · 2 shared papers, 2021–2022 · strength 0.31
  8. Yosuke Inoue · 3 shared papers, 2017–2020 · strength 0.26
  9. Hiromichi Ito · 3 shared papers, 2017–2020 · strength 0.26
  10. Yu Takahashi · 3 shared papers, 2017–2020 · strength 0.26
  11. Yoshihiro Ono · 2 shared papers, 2019–2020 · strength 0.19
  12. Shoji Kawakatsu · 2 shared papers, 2019–2020 · strength 0.19
  13. Akio Saiura · 2 shared papers, 2019–2020 · strength 0.19
  14. Sho Kiritani · 1 shared paper, 2022 · strength 0.19
  15. Ryosuke Amano · 1 shared paper, 2023 · strength 0.18
  16. Yukio Miki · 1 shared paper, 2024 · strength 0.18
  17. Hideyuki Nishiofuku · 1 shared paper, 2024 · strength 0.18
  18. Masanori Ozaki · 1 shared paper, 2024 · strength 0.18
  19. Masayuki Tanaka · 2 shared papers, 2017–2020 · strength 0.16
  20. Takeshi Sudo · 1 shared paper, 2025 · strength 0.16
  21. Hiroaki Nagano · 1 shared paper, 2025 · strength 0.16
  22. Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
  23. Sohei Satoi · 1 shared paper, 2025 · strength 0.16
  24. Dongha Lee · 1 shared paper, 2025 · strength 0.16
  25. Masafumi Imamura · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.